The protective nature of host responses in periodontal diseases

Periodontology 2000

Volumn 5, Issue 1, 1994, Pages 112-141

  Ebersole, Jeffrey L ^a   Taubman, Martin A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIUM ANTIBODY; EPITOPE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; DISEASE COURSE; DISEASE MODEL; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REVIEW; T LYMPHOCYTE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITOPES; HUMANS; IMMUNITY, CELLULAR; PERIODONTAL DISEASES; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; T-LYMPHOCYTES;

EID: 0028457301     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1994.tb00021.x     Document Type: Article

References (225)

1. The effects of periodontal therapy on serum antibody (IgG) levels to plaque microorganisms
2. Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis
3. A comparison of antibody levels to Bacteroides gingivalis in serum and crevicular fluid from patients with untreated periodontitis
4. Humoral immunity and reduced periodontal bone loss in Eikenella corrodens‐monoassociated rats
5. Intra‐oral colonization of macaque monkeys by Actinobacillus actinomycetemcomitans.
6. Serum antibody levels to oral microorganisms in children and young adults with relation to the severity of gingival disease
7. Suppression of fibroblast proliferation by oral spirochetes
8. Morphological studies on periodontal disease in the cynomolgus monkey. III. Electron microscopic observations.
9. Morphological studies on periodontal disease in the cynomolgus monkey. II. Light microscopic observations on ligature‐induced periodontitis.
10. Alveolar bone loss in rats after immunization with Actinomyces viscosus.
11. The regulation of lymphocyte traffic
12. Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high‐responder patients
13. Immunodominant antigens of Actinobacillus actinomycetemcomitans serotype b in early‐onset periodontitis patients
14. Humoral immune responses to Porphyromonas gingivalis before and following therapy in rapidly progressive periodontitis
15. Analysis of in vitro lymphoproliferative responses and antibody formation following subcutaneous infection of Actinobacillus actinomycetemcomitans and Wolinella recta in a murine model
16. Effect of immunization on experimental Bacteroides gingivalis infection in a murine model
17. Antibodies to Actinobacillus actinomycetemcomitans in a Korean population
18. Natural occurrence of black‐pigmented Bacteroides species in the gingival crevice of the squirrel monkey
19. The effects of local immunization with periodontopathic microorganisms on periodontal bone loss in gnotobiotic rats
20. Identification of the major surface protein antigens of Porphyromonas gingivalis using IgG antibody reactivity of periodontal case‐control serum
21. Periodontal disease and dental caries in relation to primary IgG subclass and other humoral immunodeficiencies
22. Oral manifestations of Sjögren's syndrome.
23. Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis.
24. Serum antibody responses in human periodontitis to cellular components of Capnocytophaga.
25. Characterization of rat T cell clones with bacterial specificity
26. Systemic humoral immune responses in periodontal disease
27. Effect of immunization with Porphyromonas gingivalis and Prevotella intermedia on disease progression in ligature‐induced periodontitis in the nonhuman primate, Macaca fascicularis.
28. Dynamics of systemic antibody responses in periodontal disease
29. Human immune responses to periodontal organisms: Capnocytophaga and Wolinella.
30. Serological identification of oral Bacteroides spp. by enzyme‐linked immunosorbent assay.
31. An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans.
32. IgG subclass antibody responses to periodontal microorganisms
33. Immunological procedures for diagnosis and risk assessment in periodontal disease.
34. Serum antibodies to periodontopathic microorganisms: specific induction.
35. Systemic antibody responses to oral microorganisms in the cynomolgus monkey: development of methodology and longitudinal responses during ligature‐induced disease
36. Molecular approaches to leucotoxin as a virulence component in Actinobacillus actinomycetemcomitans.
37. Holt SC. Murine model for virulence characteristics of periodontopathogens.
38. Characterization human serologic responses to Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus.
39. Antigenic specificities of human IgG antibody to B. gingivalis.
40. Quantitation of IgG subclass antibodies to periodontopathogens
41. Antigenic specificities of human IgG antibody to B. intermedius.
42. Humoral immune responses and diagnosis of human periodontal disease
43. Human serum antibody responses to oral microorganisms. IV. Correlation with homologous infection.
44. Human immune responses to oral microorganisms: Patterns of systemic antibody levels to Bacteroides species
45. Human immune responses to oral microorganisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to A. actinomycetemcomitans.
46. Gingival crevicular fluid antibody to oral microorganisms. I. Method of collection and analysis of antibody.
47. Effect of subgingival scaling on systemic antibody responses to oral microorganisms
48. Human immune responses to oral microorganisms. II. Serum antibody responses to antigens from Actinobacillus actinomycetemcomitans and the correlation with localized juvenile periodontitis.
49. Gingival crevicular fluid antibody to oral microorganisms. II. Distribution and specificity of local antibody responses.
50. Quantitative comparison of serum IgG antibody to periodontal microorganisms
51. Microbiological study of localized juvenile periodontitis in Panama
52. Grove DA. Coaggregation among periodontal pathogens, emphasizing Bacteroides gingivalis‐Actinomyces viscosus cohesion on a saliva‐coated mineral surface.
53. Specificity and levels of oral and systemic antibodies to Actinobacillus actinomycetemcomitans.
54. Immunization with fimbrial protein and peptide protects against Porphyromonas gingivalis induced periodontal tissue destruction
55. The ELISA system for measuring antibody reactive to Fusobacterium nucleatum in the sera of patients with chronic periodontitis
56. Serological investigation of various forms of inflammatory periodontitis
57. Serum IgG antibodies to lipopolysaccharides in various forms of periodontal disease in man
58. IL‐4 reciprocally regulates IL‐1 and IL‐1 receptor antagonist expression in human monocytes
59. Synergistic tissue destruction induced by P. gingivalis and F. nucleatum.
60. Two types of mouse helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones.
61. Bacterial penetration in the apical pocket wall of advanced human periodontitis
62. CD45RA and CD45RO positive CD4 cells in human peripheral blood and periodontal disease tissue before and after stimulation with periodontopathic bacteria
63. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans‐associated periodontal disease
64. Antigenic heterogeneity of periodontal pathogens.
65. Systemic immune responses to oral anaerobic organisms.
66. Host responses in periodontal diseases
67. Precipitating antibodies to Actinobacillus actinomycetemcomitans in localized juvenile periodontitis
68. The origin of periodontal infections
69. Human salivary acidic proline‐rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces
70. Double‐blind analysis of the relation between adult periodontitis and systemic host response to suspected periodontal pathogens
71. Human serum antibodies against Bacteroides intermedius. Antigenic heterogeneity impairs the interpretation of the host response.
72. Humoral immune response in HIV‐associated periodontal disease
73. Effects of race and periodontal status on antibody reactive with Actinobacillus actinomycetemcomitans strain Y4
74. IgG subclasses in bacterial infections
75. Factors in virulence expression and their role in periodontal disease pathogenesis
76. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis
77. Serum antibodies against the trypsin‐like protease of Bacteroides gingivalis in periodontitis
78. Specific inhibition of adherence of an oral strain of Bacteroides gingivalis antibodies against the bacterial fimbriae
79. Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease
80. Immunosuppression in severe periodontitis.
81. Detection of elevated serum antibodies to Treponema denticola in humans with advanced periodontitis by an enzyme‐linked immunosorbent assay
82. Lymphocyte activation and effector functions. Editorial overview. A return to intimacy.
83. Variation in the composition of gingival inflammatory cell infiltrates
84. Effects of treatment on antibody titer to Porphyromonas gingivalis in gingival crevicular fluid of patients with rapidly progressive periodontitis
85. Porphyromonas gingivalis virulence in mice. Induction of immunity to bacterial components.
86. Virulence of Wolinella recta in a murine abscess model
87. Clinical and microbiological effects of localized ligature‐induced periodontitis on non‐ligated sites in the cynomolgus monkey
88. Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18
89. Robertson PB. The microbiology of ligature‐induced periodontitis in the cynomolgus monkey.
90. Host responses to bacteria and bacterial products in periodontal disease: immunosuppressive effects of periodontitis‐related microorganisms?
91. Hamada S. Generation of specific antibody‐secreting cells in salivary glands of BALB/c mice following parenteral in oral immunization with Porphyromonas gingivalis.
92. Evian CI, Dougherty P. Serum IgA and IgG antibodies to Treponema vincentii and Treponema denticola in adult periodontitis, juvenile periodontitis and periodontally healthy subjects.
93. Oral manifestations of primary and acquired immunodeficiency diseases in children
94. r streptococcal antigen
95. Cellular immunity in periodontal disease. An overview
96. Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis
97. Comparative antibody titers to Actinobacillus actinomycetemcomitans in juvenile periodontitis, chronic periodontitis and periodontally healthy subjects
98. Bacteriology of human experimental gingivitis: effect of plaque and gingivitis score.
99. Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients
100. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b
101. Diminished immunoglobulin synthesis after stimulation of mononuclear cells from periodontal disease tissue
102. Immune protection against P. gingivalis infection in a murine abscess model.
103. Naive and memory T‐cells show distinct pathways of lymphocyte recirculation
104. T‐cell memory: the connection between function, phenotype and migration pathways
105. Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease
106. IgG subclasses in human periodontal disease. III. Serum concentrations of IgG subclass immunoglobulins and circulating immune complexes.
107. Reciprocal regulatory effects of IFN‐γ and IL‐4 on the in vitro development of human Th1 and Th2 clones
108. Clinical immunologic and microbiologic features of active disease sites in juvenile periodontitis
109. Measurement of serum and salivary antibodies to Bacteroides asaccharolyticus in human subjects
110. Local and systemic immunoglobulins reactive to Bacteroides gingivalis in rapidly progressive and adult periodontitis
111. Biological activities of outer membrane vesicles
112. Immunoregulation in severe generalized periodontitis
113. Specific antibodies and their potential role in periodontal diseases
114. Modulation of colonization by black‐pigmented Bacteroides species in squirrel monkeys by immunization with Bacteroides gingivalis.
115. Leukotoxic effects of Actinobacillus actinomycetemcomitans modulation by serum components
116. Cellular analysis of functional mononuclear cells from chronically inflamed gingival tissue
117. Humoral antibody response against Bacteroides gingivalis‐specific antigen recognized by monoclonal antibody in adult periodontal patients
118. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties
119. Serum antibodies to Bacteroides gingivalis in periodontitis: a longitudinal study
120. Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periodontal disease
121. Evidence for a role of VLA integrins in lymphocyte‐human gingival fibroblast adherence
122. Serum immunoglobulin G antibody to periodontal bacteria
123. Microbiology of HIV‐associated gingivitis and periodontitis.
124. Detection of specific antibody in adult human periodontitis sera to surface antigens of Bacteroides gingivalis.
125. Immunoglobulin G response to subgingival gram‐negative bacteria in human subjects
126. Serological studies of oral Bacteroides intermedius.
127. Morphological studies on periodontal disease in the cynomolgus monkey
128. Effects of immunization with B. macacae on induced periodontitis – preliminary findings.
129. Humoral immunologic responses in idiopathic juvenile periodontitis (periodontosis)
130. Bacteroides gingivalis, Bacteroides asaccharolyticus and Bacteroides melaninogenicus cell surface morphology and adherence to erythrocytes and human buccal epithelial cells
131. Purification and properties of hemagglutinin from culture supernatant of Bacteroides gingivalis.
132. The immunodominant outer membrane antigen of Actinobacillus actinomycetemcomitans is located in the serotype‐specific high molecular mass carbohydrate moiety of lipopolysaccharide
133. Serum antibodies to Bacteroides species in human periodontitis
134. Macaca nemestrina: a non‐human primate model for studies of periodontal disease
135. Macaca fascicularis as a model in which to assess the safety and efficacy of a vaccine for periodontitis
136. Physiological and molecular mechanisms of lymphocyte homing
137. Differential expression of homing associated adhesion molecules by T‐cell subsets in man
138. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte‐associated antigen, a tissue‐selective homing receptor for skin‐homing T cells.
139. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L‐selection on T cells during the virgin to memory cell transition.
140. Identification of subsets of human T‐cells capable of enhanced transendothelial migration
141. The distribution and transmission of Actinobacillus actinomycetemcomitans in families with established adult periodontitis
142. Periodontal status of patients with abnormalities of the immune system. II. Observations over a 2‐year period.
143. Periodontal status of patients with abnormalities of the immune system
144. In situ correlative immuno‐identification of mononuclear infiltrates invasive bacteria in diseased gingiva
145. Relative avidity of serum immunoglobulin G antibody for the fimbria antigen of Actinobacillus actinomycetemcomitans in patients with adult periodontitis
146. Human naive and memory T cells
147. Degradation of human secretory immunoglobulin by a protease isolated from the anaerobic periodontopathogenic bacterium Bacteroides gingivalis.
148. IgG subclass distribution of serum antibodies against lipopolysaccharide from Bacteroides gingivalis in periodontal health and disease
149. Modification of experimental Porphyromonas gingivalis murine infection by immunization with a polysaccharide‐protein conjugate
150. ‐ T‐cell subsets in the regulation of parasite immunity and disease
151. Characterization of treponemes isolated from human and non‐human primate periodontal pockets
152. The identification of lymphoid cell subpopulations in sections of human lymphoid tissue and gingivitis in children using monoclonal antibodies.
153. Immunopathogenesis of chronic inflammatory periodontal disease: Cellular and molecular mechanisms
154. Experimental gingivitis in humans. A histochemical and immunologic characterization of the lymphoid cell subpopulation.
155. Conversion of a stable T‐cell lesion to a progressive B‐cell lesion in the pathogenesis of chronic inflammatory periodontal disease
156. Suppression of human peripheral blood lymphocytes by Fusobacterium nucleatum.
157. Taichman NS. Suppression of human lymphocyte responses by oral spirochetes a monocyte dependent phenomenon.
158. Immunomodulatory effects of Bacteroides products on in vitro human lymphocyte functions
159. Immunologic dysfunction in the pathogenesis of periodontal diseases
160. Migration of Th1 and Th2 A. actinomycetemcomitans‐specific clones into infected and noninfected gingival tissues.
161. Non‐human primates used in studies of periodontal disease pathogenesis: a review of the literature
162. Page R, Whitney C, Engel D. Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.
163. Longitudinal study of experimentally induced periodontal disease in Macaca arctoides: relationship between microflora and alveolar bone loss
164. Bacterial specificity in adult periodontitis. A summary of recent work.
165. Treponema pectinovorum sp. nov. isolated from humans with periodontitis.
166. Treponema socranskii sp. nov.; Treponema socranskii subsp. socranskii subsp. nov; Treponema socranskii subsp. buccale subsp. nov.; and Treponema socranskii subsp. paredis subsp. nov. isolated from humans with experimental gingivitis and periodontitis.
167. Gingival crevicular fluid antibody to oral microorganisms. III. Association of antibody levels in gingival homogenates with gingival crevicular fluid.
168. Synergistic interactions between interleukin 1, tumor necrosis factor and lymphotoxin in bone resorption
169. Adhesion molecules controlling lymphocyte migration
170. Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues
171. A method for studying immunoglobulin synthesis by gingival cells
172. Local and systemic production of immunoglobulins to periodontopathogens in periodontal disease
173. Effect of periodontal therapy on spontaneous lymphocyte response and neutrophil chemotaxis in localized and generalized juvenile periodontitis patients
174. Leukocidal mechanisms of Actinobacillus actinomycetemcomitans.
175. Cytopathic effects of Actinobacillus actinomycetemcomitans on monkey blood leukocytes
176. Cytokine profiles of gingival mononuclear cells from periodontal disease patients
177. Expression of interleukin‐2 receptor and HLA‐DR on lymphocyte subsets of gingival crevicular fluid in patients with periodontitis
178. Wolinella gen. nov., Wolinella succinogenes (Vibrio succinogenes Wolin et. al.) comb, nov., and description of Bacteroides gracilis sp. nov. Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from humans with periodontal disease.
179. Wolinella recta, Campylobacter concisus, Bacteroides gracilis. and Eikenella corrodens from periodontal lesions.
180. A study of the bacteria associated with advancing periodontitis in man
181. Wolinella curva, spp. nov. (Vibrio succinogenes of human origin) a species distinct from Wolinella succinogenes and Wolinella recta.
182. Periodontal bone loss in ovalbumin sensitized germfree rats fed antigen‐free diet with ovalbumin
183. Serum antibody and homologous infection in subjects with destructive periodontal diseases
184. Association between systemic and local antibody and periodontal diseases.
185. Phenotypic studies of cells from periodontal disease tissues
186. The cellular basis of host responses in periodontal diseases.
187. Host response in experimental periodontal disease
188. Immune response and periodontal bone loss in germfree rats immunized and infected with Actinobacillus actinomycetemcomitans.
189. Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis
190. Serum antibody reactive with predominant organisms in the subgingival flora of young adults with generalized severe periodontitis
191. Serum antibodies in young adult humans reactive with periodontitis associated treponemes
192. The effect of immunosuppressive agents on periodontal disease in man
193. Cross‐sectional study of the effects of immunosuppressive agents on humoral immune responses to 6 oral microorganisms in humans
194. Relationship between periodontal disease activity and serum antibody titres to oral bacteria.
195. Antigens released from four oral bacteria in periodontitis
196. Enzyme‐linked immunosorbent assay for human IgG, IgA, and IgM antibodies to antigens from anaerobic cultures of seven oral bacteria
197. Extraction and partial characterization of a leukotoxin from a plaque‐derived gram‐negative microorganism
198. Genco RJ, Taichman NS. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis.
199. Serum antibody activity against Actinobacillus actinomycetemcomitans in Chinese patients with periodontitis
200. Role neutrophils in host defense to periodontal infections.
201. de Graaff J. Virulence of black‐pigmented Bacteroides strains from periodontal pockets and other sites in experimentally induced skin lesions in mice.
202. IgG and IgG subclasses in human periodontosis (juvenile periodontitis). Serum concentrations.
203. Administration of recombinant IL‐4 to humans regulates gene expression, phenotype and function in circulating monocytes
204. + cells on immunoglobulin synthesis by gingival lymphocytes
205. Antigens of Actinobacillus actinomycetemcomitans identified by immunoblotting with sera from patients with localized human juvenile periodontitis and generalized severe periodontitis
206. Detection of immunodominant antigens of periodontopathic bacteria in human periodontal disease
207. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide
208. Interleukin‐1β and IgG subclass concentrations in gingival crevicular fluid from patients with adult periodontitis
209. Elevated opsonic activity for Porphyromonas (Bacteroides) gingivalis in serum from patients with a history of destructive periodontal disease. A case:control study.
210. Clinical description and etiology of HIV‐associated periodontal diseases.
211. Periodontal disease – potential intraoral expression of AIDS may be a rapidly progressive periodontitis
212. Cytokine patterns of immunologically mediated tissue damage
213. Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans‐specific T helper cells on periodontal disease
214. Periodontal bone loss and immune characteristics of congenitally athymic and thymus cell‐reconstituted athymic rats
215. Periodontal bone loss and immune characteristics after adoptive transfer of Actinobacillus‐sensitized T cells to rats
216. Detection of specific antibodies against fimbriae and membrane proteins from the oral anaerobe Bacteroides gingivalis in patients with periodontal diseases
217. Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
218. Actinobacillus actinomycetemcomitans in human periodontal disease